The Incidence and Relative Risk of PD-1/PD-L1 Inhibitors-Related Colitis in Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials

Mapping Intimacies ◽

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2457 ◽

2020 ◽

Author(s):

L. Lin ◽

X. Chen

Keyword(s):

Lung Cancer ◽

Relative Risk ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

The incidence and relative risk of PD-1/PD-L1 inhibitors-related colitis in non-small cell lung cancer: A meta-analysis of randomized controlled trials

International Immunopharmacology ◽

10.1016/j.intimp.2019.105975 ◽

2019 ◽

Vol 77 ◽

pp. 105975

Author(s):

Lan-Lan Lin ◽

Guo-Fu Lin ◽

Qiong Luo ◽

Xiang-Qi Chen

Keyword(s):

Lung Cancer ◽

Relative Risk ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

The benefits and risks of CTLA4 inhibitor plus PD1/PDL1 inhibitor in stage IIIB/IV non‐small cell lung cancer: A systematic analysis and meta‐analysis based on randomized controlled trials

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13465 ◽

2021 ◽

Author(s):

Qiangyun Liu ◽

Zige Fang ◽

Miaowen Liu ◽

Ruoxin Xu ◽

Fengming Yi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Systematic Analysis ◽

Randomized Controlled

Download Full-text

Risk profile of bevacizumab in patients with non-small cell lung cancer: A meta-analysis of randomized controlled trials

Acta Oncologica ◽

10.3109/0284186x.2011.631579 ◽

2011 ◽

Vol 51 (2) ◽

pp. 151-156 ◽

Author(s):

Chao Cao ◽

Jianmiao Wang ◽

Hansvin Bunjhoo ◽

Yongjian Xu ◽

Huijuan Fang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Risk Profile ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

The Impact of Afatinib on Survival in Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials

Journal of Cancer ◽

10.7150/jca.27528 ◽

2019 ◽

Vol 10 (4) ◽

pp. 885-892

Author(s):

Chi Wang ◽

Yun Li ◽

Li Ke ◽

Lejie Cao ◽

Pingsheng Fan ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled ◽

Download Full-text

Maintenance erlotinib improves clinical outcomes of unresectable advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials

Experimental and Therapeutic Medicine ◽

10.3892/etm.2012.690 ◽

2012 ◽

Vol 4 (5) ◽

pp. 849-858 ◽

Author(s):

JIAN ZHANG ◽

WEIQING ZHANG ◽

SHAOHONG HUANG ◽

HUI LI ◽

YUN LI ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Clinical Outcomes ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

Comparison between cisplatin plus vinorelbine and cisplatin plus docetaxel in the treatment of advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials

Molecular and Clinical Oncology ◽

10.3892/mco.2013.210 ◽

2013 ◽

Vol 2 (1) ◽

pp. 146-150 ◽

Author(s):

GUODONG SHEN ◽

GENG BIAN ◽

HAIYING YU ◽

MIN GAO ◽

DONGMEI KANG ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

Cetuximab-based Therapy is Effective in Chemotherapy-naïve Patients with Advanced and Metastatic Non-small-cell Lung Cancer: A Meta-analysis of Randomized Controlled Trials

Lung ◽

10.1007/s00408-011-9286-3 ◽

2011 ◽

Vol 189 (3) ◽

pp. 193-198 ◽

Author(s):

Ezzeldin M. Ibrahim ◽

Khaled M. Abouelkhair ◽

Osama A. Al-Masri ◽

Najeeb C. Chaudry ◽

Ghieth A. Kazkaz

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

Risk of adverse events with bevacizumab addition to therapy in advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials

OncoTargets and Therapy ◽

10.2147/ott.s96156 ◽

2016 ◽

pp. 2421 ◽

Author(s):

Han Yang ◽

Xi-Xi Lai ◽

Ren-Ai Xu ◽

Yu-Ping Li

Keyword(s):

Lung Cancer ◽

Adverse Events ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

Efficacy and Safety of Sorafenib for Advanced Non-Small Cell Lung Cancer: a Meta-analysis of Randomized Controlled Trials

Asian Pacific Journal of Cancer Prevention ◽

10.7314/apjcp.2014.15.14.5691 ◽

2014 ◽

Vol 15 (14) ◽

pp. 5691-5696 ◽

Author(s):

Wei-Lan Wang ◽

Zhi-Hui Tang ◽

Ting-Ting Xie ◽

Bing-Kun Xiao ◽

Xin-Yu Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

Thymosin plus cisplatin with vinorelbine or gemcitabine for non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials

Thoracic Cancer ◽

10.1111/j.1759-7714.2011.00057.x ◽

2011 ◽

Vol 2 (4) ◽

pp. 213-220 ◽

Author(s):

Jin Jiang ◽

Xiaojing Wang ◽

Jinhui Tian ◽

Lun Li ◽

Qiao Lin

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text